Alfacell Corporation
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement With BL&H for South Korea, Taiwan and Hong Kong
Published in Oncology Business Week, February 10th, 2008
Alfacell Corporation (NASDAQ:ACEL) announced that it has entered into a distribution agreement with BL&H Co. Ltd., a leading pharmaceutical company in Southeast Asia, for the commercialization of ONCONASE(R) (ranpirnase) in South Korea, Taiwan and Hong Kong. ONCONASE, the company's lead drug candidate, is currently being evaluated as a treatment for unresectable malignant mesothelioma (UMM) in a confirmatory Phase IIIb clinical trial.
Under the agreement, Alfacell has granted BL&H exclusive rights in the defined territory for the marketing, sales and distribution of ONCONASE. Alfacell has received an up-front fee of $100,000 and is eligible for milestone payments based...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Bederra Corporation
Bederra Corporation Announces Acquisition of Diagnos, Inc. - Benda Pharmaceutical, Inc.
Benda Updates $3.8 MM Gendicine(R) Order Status - Revenue Realization Ahead of Schedule - Better Health Publishing
Breakthrough Study Links Prostate Cancer, Depression, IBS, Adrenal Fatigue and Allergies to Lead and Mercury Toxic Load in Body - Biotechnology Business
ImmuneRegen BioSciences Signs Material Transfer Agreement with Celgene Cellular Therapeutics - Bladder Cancer
Geron and Sienna Enter Into License Agreement for Cancer Diagnostics - Brain Cancer
Calibrant Announces Brain Cancer Drug Discovery Program with Cleveland Clinic - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
